1. Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability‐high/mismatch repair‐deficient or POLE‐mutated metastatic or unresectable colorectal cancer. Issue 12 (1st March 2022) Authors: Oh, Chung Ryul; Kim, Jeong Eun; Hong, Yong Sang; Kim, Sun Young; Ahn, Joong Bae; Baek, Ji Yeon; Lee, Myung‐Ah; Kang, Myoung Joo; Cho, Sang Hee; Beom, Seung‐Hoon; Kim, Tae Won Journal: International journal of cancer Issue: Volume 150:Issue 12(2022) Page Start: 2038 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗